Max Planck Institute, Qiagen develop latent TB test; University of Exeter creates £20 million research center;

> Max Planck Institute for Infection Biology and Qiagen are developing a multiple biomarker test for people with latent tuberculosis that could identify their risk of developing the full-blown disease. Press release

> A new £20 million interdisciplinary research center at the University of Exeter will bring together researchers from biology, medicine, engineering mathematics and physics in translational research, including biomarker discovery. Press release

> Researchers have found the receptor for the breast cancer biomarker tumor differentiating factor (TDF). Press release

> Urine biomarkers could help in the emergency identification of acute kidney injury, thereby helping to speed up treatment. Press release

> C-reactive protein shows clinical use in kidney cancer, identifying patients at high risk of recurrence. Study

> A serum protein shows potential as a biomarker in liver cancer. Abstract

> Spinal fluid biomarkers link up with memory tests in mild cognitive impairment, a precursor of Alzheimer's disease. Abstract

Suggested Articles

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.

Cybernet Manufacturing, maker of medical-grade computer monitors, has unveiled a new, large touchscreen designed to protect against infections.

A startup has raised $12 million to fund its real-time system for monitoring patients undergoing dialysis at home and calling in complications.